ArticleAllergy2016

Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.

P Khoury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.